Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-03-27
2007-03-27
Kemmerer, Elizabeth (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200
Reexamination Certificate
active
10385064
ABSTRACT:
Disclosed are 1) amino acid sequence data, structural features, homologies and various other data characterizing morphogenic proteins, 2) methods of producing these proteins from natural and recombinant sources and from synthetic constructs, 3) morphogenic devices comprising these morphogenic proteins and a suitably modified tissue-specific matrix, and 4) methods of inducing non-chondrogenic tissue growth in a mammal.
REFERENCES:
patent: 4721096 (1988-01-01), Naughton et al.
patent: 4861757 (1989-08-01), Antoniades et al.
patent: 4877864 (1989-10-01), Wang et al.
patent: 4919939 (1990-04-01), Baker
patent: 4935497 (1990-06-01), Veis et al.
patent: 4946437 (1990-08-01), Sredni et al.
patent: 4968590 (1990-11-01), Kuberasampath et al.
patent: 4975526 (1990-12-01), Kuberasampath et al.
patent: 4983581 (1991-01-01), Antoniades et al.
patent: 5002488 (1991-03-01), Homsy
patent: 5011691 (1991-04-01), Oppermann et al.
patent: 5013649 (1991-05-01), Wang et al.
patent: 5108989 (1992-04-01), Amento et al.
patent: 5124316 (1992-06-01), Antoniades et al.
patent: 5141905 (1992-08-01), Rosen et al.
patent: 5186931 (1993-02-01), Kishimoto et al.
patent: 5197882 (1993-03-01), Jernberg
patent: 5368859 (1994-11-01), Dunn et al.
patent: 5635373 (1997-06-01), Wozney et al.
patent: 5849686 (1998-12-01), Kuberasampath et al.
patent: 6034062 (2000-03-01), Thies et al.
patent: 6090776 (2000-07-01), Kuberasampath et al.
patent: 6194376 (2001-02-01), Kuberasampath et al.
patent: 6288031 (2001-09-01), Kuberasampath et al.
patent: 6498142 (2002-12-01), Sampath et al.
patent: 6861404 (2005-03-01), Cohen et al.
patent: 2004/0126375 (2004-07-01), Langenfeld
patent: 0148155 (1985-07-01), None
patent: 0416578 (1991-03-01), None
patent: 0495284 (1992-07-01), None
patent: 0 661 987 (1998-01-01), None
patent: WO 84/01106 (1984-03-01), None
patent: WO 88/00205 (1988-01-01), None
patent: WO 89/09787 (1989-10-01), None
patent: WO 89/09788 (1989-11-01), None
patent: WO 89/10409 (1989-11-01), None
patent: WO 89/11862 (1989-12-01), None
patent: WO 90/03733 (1990-04-01), None
patent: WO 90/10017 (1990-09-01), None
patent: WO 90/11366 (1990-10-01), None
patent: WO 91/05802 (1991-05-01), None
patent: WO 91/18558 (1991-12-01), None
patent: WO 92/00382 (1992-01-01), None
patent: WO 92/14481 (1992-09-01), None
patent: WO 92/15323 (1992-09-01), None
patent: WO 93/00432 (1993-01-01), None
patent: WO 93/04692 (1993-03-01), None
patent: WO 93/09229 (1993-05-01), None
patent: WO 98/51354 (1998-11-01), None
patent: WO 99/21574 (1999-05-01), None
patent: WO 00/21998 (2000-04-01), None
patent: WO 01/74379 (2001-10-01), None
Vukicevic et al., 1996, PNAS USA 93 :9021-9026.
Border et al., 1994, New England Journal of Medicine 331:1286-1292.
Asahina et al., “Human Osteogenic Protein-1 (hOP-1) Induces Chondroblastic Differentiation Of Osteoprogenitor Cells Derived From Newborn Rat Calvaria”,Bone and Mineral Research, 7:S205 452 (1992).
Basler et al. Control of Cell Pattern in the Neural Tube: Regulation of Cell Differentiation by dorsalin-1, a Novel TGF-beta Family Member. Cell 73, 687-702 (1993).
Begue-Kim et al. Effects of Dentin Proteins, Transforming Growth Factor Beta1 and Bone Morphogenetic Protein 2 (BMP2) on the Differentiation of Odontoblast in vitro. Int. J. Dev. Biol. 36, 491-503 (1992).
Behringer et al. Abnormal Sexual Development in Transgenic Mice Chronically Expressing Mullerian Inhibiting Substance. Nature 345, 167-170 (1990).
Border, et al., “Suppression of experimental Glomerulonephritis by antiserum against transforming growth factor ∃1”,Nature, 346:371-374 (1990).
Border, et al., “Transforming Growth Factor-∃ in Disease: The Dark Side of Tissue Repair”,J. Clin. Invest., 90:1-7 (1992).
Broxmeyer et al., “Human umbilical cord blood as a potential source of transplantable hematopietic stem/progenitor cells”,Proc. Natl. Acad. Sci., 86:3828-3832 (1989).
Castilla et al., Transforming Growth Factors ∃1 and ∀ in Chronic Liver DiseaseNew England Journal of Medicine, 324:933-939 (1991).
Cate et al. Isolation of the Bovine and Human Genes for Mullerian Inhibiting Substance and Expression of the Human Gene in Animal Cells. Cell 45,685-698 (1986).
Celeste et al. “Highly Purified Bovine Bone-Inductive Activity Contains Multiple Protein Species Related to BMP-2”,Journal of Cellular Biochemistry, 54:105 (1990).
Celeste et al. Identification of Transforming Growth Factor Beta Family Members Present in Bone-Inductive Protein Purified from Bovine Bone. PNAS 87, 9843-9847 (1990).
Celeste et al., “Molecular Cloning of BMP-8: A Protein Present in Bovine Bone Which is Highly Related to the BMP-5/6/7 Subfamily of Osteoinductive Molecules”,Journal of Cellular Biochemistry, Suppl. 16F 100W502 (1992).
Cheifetz t al., “A Surface Component on GH3 Pituitary Cells That Recognizes Transforming Growth Factor-∃, Activin, and Inhibin”,Journal of Biological Ch mistry, 263:17225-17228 (1988).
Chen et al. Bone Morphogenetic Protein-2b Stimulation of Growth and Osteogenic Phenotypes in Rat Osteoblast-like Cells: Comparison with TGF-Beta. J. Bone Min. Res. 6, 1387-1393 (1991).
Chomcyznski et al. Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanant-Phenol-Chloroform Extraction. Anal. Biochem. 162, 156-169 (1987).
Clark et al., “Coregulation of Collagenase and Collagenase Inhibitor Production by Phorbol Myristate Acetate in Human Skin Fibroblasts”,Arch. Bio. Chem. Biophys., 241:36-44 (1985).
Coffman et al., “Xotch, the Xenopus Homolog ofDrosophila notch”, Science, 249:1438-1441 (1990).
Dahlin et al. “Generation of New Bone Around Titanium Implants Using a Membrane Technique: An Experimental Study in Rabbits”,International Journal of Oral&Maxillofacial Implants, 4:19-25 (1989).
D'Allesandro et al. Purification, Characterization and Activity of Recombinant Human BMP-5. J. Cell Biochem. Suppl. 166, Abstract No. Q105 (1991).
Dexter et al., “Growth and Differentiation on the Hemopoietic System”,Ann. Rev. Cell Biol., 3:423-441 (1987).
Fausto et al., “Effects of TGF- s in the liver: cell proliferation and fibrogenesis”,Ciba Found. Symp., 157:165-174 (1991).
Fitgerald et al. (1990), “Autoradiographic Analysis of Odontoblast Replacement Following Pupl Exposure In Primate Teeth,” 35Archs. Oral Biol. 9:707-715.
Fitzgerald et al. (1991), “A Clinical and Histological Evaluation of Conservative Pulpal Therapy in Human Teeth,” 16Operative Dentistry101-112.
Forage et al., “Cloning and sequence analysis of cDNA species coding for the two subunits of inhibin from bovine follicular fluid”,Proc. Natl. Acad. Sci., 83:3091-3095 (1986).
George et al., “Current Methods in Sequence Comparison and Analysis”,Macromolecular Sequencing and Synthesis Selected Methods and Applications, 127-149 (1988).
Gray et al., “Requirement for Activin A and Transforming Growth Factor- 1 Pro-Regions in Homodimer Assembly”,Science, 247:1328-1330 (1990).
Green et al. Graded Changes in Dose of a Xenopus Activin A Homologue Elicit Stepwise Transitions in Embryonic Cell Fate. Nature 347, 391-394 (1990).
Hall et al., “Stem Cells: the generation and maintenance of cellular diversity”,Development, 106:619-633 (1989).
Haskell et al. (1978), “Dir ct Pulp Capping Treatment: A Long-T rm Follow-Up,” 97JADA607-612.
Heath et al., “Regulatory factors of embryonic stem cells”,J. Cell. Sci., Suppl. 10:257-266 (1988).
Heikinheimo (1994), “Stage-Specific Expression of Decapentaplegic-Vg-Related Genes 2, 4, and 6 (Bone Morphogenetic Proteins 2, 4, and 6) During Human Tooth Morphogenesis,” 73J. Dent. Res. 3:590-597.
Helder et al. (1995), “Expression Pattern of Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in Human and Mouse Development,” 43J. Histochem. Cytochem. 10:1035-1044.
Israel et al., “Expression and Characterization of Bone Morphogenetic Protein-
Cohen Charles M.
Oppermann Hermann
Pang Roy H. L.
Rueger David C.
Sampath Kuber T.
Curis, Inc.
Fish & Neave IP Group Ropes & Gray LLP
Kemmerer Elizabeth
LandOfFree
Protein-induced morphogenesis of kidney tissue does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein-induced morphogenesis of kidney tissue, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein-induced morphogenesis of kidney tissue will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3773324